SELARSDI, biosimilar to Stelara, rolls out in U.S.
SELARSDI is the second biosimilar to launch in the U.S. under the Teva and Alvotech strategic partnership, which includes nine products.
Pharmacy
Walgreens supports the American Heart Association to help bring CPR to communities nationwide
Walgreens multi-year, $15 million fundraising commitment includes a point-of-sale donation campaign to enhance the lifesaving capacity of the American Heart Association.
Secure dialing extends the power of mobile e-prescribing for health care providers
Calls made through the app display the practice’s designated office number, maintaining professional boundaries and presenting patients with a number they are likely to recognize and trust.
Head of food division at FDA resigns, citing numerous job cuts
Jones pointed to the layoffs of 89 staffers in the food division, cuts he called “indiscriminate.”
Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid
If approved, Dupixent would be the first and only targeted medicine to treat BP in the US; FDA decision expected by June 20, 2025.
Jim Tsipakis makes Giant Eagle a holistic space
“Our pharmacy business has never been stronger. We continue to grow and fill the needs of our guests,” Tsipakis says.
2025 Health Care Outlook: Micah Cost, PQA
By Micah Cost, CEO, Pharmacy Quality Alliance (PQA)
2025 Health Care Outlook: Sandra Hanna, Neighbourhood Pharmacies
By Sandra Hanna, CEO Neighbourhood Pharmacies.
Ana Archbold on Dr. Reddy’s women’s health business
Ana Archbold is responsible for setting and executing the broader strategy for the company’s Self-Care and Wellness division in the U.S.
AAM says Inflation Reduction Act undermines generic and biosimilar competition
The AAM warns that IRA price controls may reduce generics and biosimilars, slowing competition and keeping drug prices high.
RFK Jr. confirmed as health secretary
The senate vote was split nearly along party lines. Industry organizations respond to confirmation.
VillageMD talks to advisers as Walgreens pursues exit plan
Walgreens chief executive Officer Tim Wentworth said on an earnings call last month that the company plans to divest VillageMD and use any proceeds to reduce debt and improve its balance sheet.
Glenmark Pharmaceuticals intros clindamycin phosphate foam, 1%
According to IQVIA sales data for the 12-month period ending December 2024, the Evoclin Foam, 1% market achieved annual sales of approximately $5.8 million.
Walgreens Flu Index tracks 4 consecutive weeks of increased flu activity
For 11 years, the Walgreens Flu Index has provided an early and accurate view of disease trends. The last four consecutive weeks of data have shown increasing flu activity across the U.S.
Why consumer experience is clinically important in health care
Findings from a CVS Health analysis show how consumer satisfaction is linked to health-related outcomes.
Upsher-Smith and NASPA announce the recipients of the 2024 NASPA Excellence in Innovation Award
Each year, more than 40 state pharmacy associations present the award to deserving recipients.